WESTLAKE VILLAGE, Calif., April 02, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, is pleased to announce that Padagis Israel Pharmaceuticals Ltd., Padagis US LLC, and Padagis LLC (Padagis) have requested a stay to the ongoing patent litigation between Padagis and the Company, and the Company has agreed to enter a joint stipulation to stay the case, which was filed in the U.S. District Court for the District of Delaware on April 2, 2025. After the Court enters the joint stipulation, all calendared dates and trial for the patent litigation will be vacated. As part of the joint stipulation agreement, Padagis is required to report to Arcutis any U.S. Food and Drug Administration (FDA) correspondence...

REGINA, Saskatchewan, April 02, 2025 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISC) (“ISC” or the “Company”) confirms that the Board of Directors (the “Board”) of the Company is aware of the news release issued this morning related to a tender offer by Plantro Ltd. to acquire up to 15% of Class A Limited Voting Shares of ISC. The Board was first contacted by Plantro Ltd. in relation to this matter on March 31, 2025 and is reviewing and will assess this offer on its merits. The Company has a long and proven track record of success. It remains focussed on executing on its 2028 goal to double the size of the Company on a revenue and adjusted EBITDA basis, based on its actual 2023 revenue and adjusted EBITDA, and maximizing shareholder value. About ISC®Headquartered in Canada, ISC is a leading provider of registry and...

Company announcementfor ROCKWOOL A/SRelease no. 18 – 2025to Nasdaq Copenhagen         2 April 2025 Minutes of Annual General Meeting 2025 The annual general meeting of ROCKWOOL A/S was held on 2 April 2025 at 3:00 p.m. at Roskilde Kongrescenter, Denmark. At the general meeting, the board of directors’ report for the financial year of 2024 was noted, the annual report for 2024 was approved and the management and the board of directors were discharged from liability. Furthermore, the remuneration report for 2024 was approved. The general meeting approved the remuneration of the board of directors, including the remuneration of members of the Audit Committee and the Remuneration and Nomination Committee, respectively, for the period from the annual general meeting in 2025 to the annual general meeting in 2026. The general meeting approved...

Oslo, 2 April 2025: Two board members have today bought shares in Scatec ASA. Mette Krogsrud, board member of Scatec ASA, has on 2 April bought 3,000 shares in Scatec ASA at an average price per share of 77.00. After the transaction Mette Krogsrud owns 6,000 shares in Scatec ASA. Ketal AS, a company controlled by Maria Tallaksen, board member of Scatec ASA, has on 2 April bought 1,300 shares in Scatec ASA at an average price per share of NOK 77.54. After the transaction Ketal AS owns 1,300 shares in Scatec ASA. Attached is the notification of the transaction in accordance with the Market Abuse Regulation Article 19. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading act.Attachments250402 – Notification...

(2025-04-02) Kitron updates its financial outlook due to strong demand within the Defence/Aerospace market sector along with a gradual recovery in other segments. At this time, Kitron expects revenues for the full year 2025 to be between EUR 640 and 710 million. Operating profit (EBIT) is expected to be between EUR 47 and 65 million. The previous outlook was for revenues between EUR 600 and 700 million, with an operating profit (EBIT) between EUR 42 and 63 million. Peter Nilsson, Kitron’s CEO, comments: “Defence demand is strong and growing, driven by geopolitics and reindustrialization of European defence capabilities, and we see that we can scale our current operations to handle the expected growth. For other market sectors, the picture is more balanced. There are global uncertainties related to tariffs, but changes also create...

Shareholders’ Meeting set for May 15, 2025 Wendel informs its shareholders that the Shareholders’ Meeting will be held on Thursday May 15, 2025, at 3 p.m. (Paris time) at the Auditorium Cézanne Saint-Honoré, located at 2-4, rue Paul-Cézanne, 75008 Paris. The notice of meeting, being worth convening notice, is published today in French in the Bulletin des Annonces Légales et Obligatoires (www.journal-officiel.gouv.fr/balo/). It includes notably the agenda, the draft resolutions which will be presented to the Meeting and the conditions to take part in the Meeting. It is also available on the Wendel website. Other documents and information concerning this Meeting will be available to shareholders and published as from April 24, 2025, under legal and regulatory conditions, on the dedicated page of the Wendel website www.wendelgroup.com/en/annual-general-meetings....

Heimar hf. (“Heimar”) has terminated its market making agreement with Landsbankinn hf. regarding market making for bonds issued by Heimar, identified by the ticker symbol HEIMAR290547, and listed on Nasdaq Iceland. The termination has already taken effect. For further information, please contact Björn Eyþór Benediktsson, CFO of Heimar hf., at eythor@heimar.is Please note that in case of discrepancy in the English and the Icelandic versions, the Icelandic version shall prevail

Paris – 2 April 2025 Convening of the Annual General Meeting of Banijay Group N.V. Banijay Group N.V. today announced that the Annual General Meeting (“General Meeting”) will take place on Thursday 22 May 2025 at 2:00 pm CET at Mediarena 2, 1114 BC Amsterdam-Duivendrecht, the Netherlands. The agenda for the meeting is as follows:Opening Report of the Financial Year 2024 Remuneration report 2024, which is included in the 2024 Universal Registration Document (advisory vote) Discussion on the corporate governance chapter, which is included in the 2024 Universal Registration Document (advisory vote) Annual accounts 2024Adoption of the annual accounts 2024 that are included in the 2024 Universal Registration Document (voting item) Distribution over Financial Year 2024 (voting item) Discharge members of the Management BoardDischarge...